Table 2.

	CORTEX
	NE	DA	5-HT	MHPG	DOPAC	HVA	5-HIAA	MHPG/NE	DOPAC/DA	HVA/DA	5-HIAA/5-HT
IVT VEH (N=6)	0.254 ±0.011	1.045 ±0.113	0.985 ±0.063	0.558 ±0.031	0.170 ±0.006	0.264 ±0.019	0.710 ±0 951	2.032 ±0.112	0.162 ±0.028	0.218 ±0.016	0.679 ±0.071
IVT DSP4 (N=11)	0.217 ±0.024	1.C52 ±0.176	0.840 ±0.071	0.467 ±0.098	0.145 ±0.019	0.236 ±0.031	0.637 ±0.102	1.768 ±0.314	0.175 ±0.0429	0246 ±0.050	0.772 ±0.181
	HYPOTHALAMUS
IVT VEH	0.645 ±0.086	0.346 ±0.117	0.887 ±0.229	0894 ±0.116	0.094 ±0.030	0.153 ±0.036	1.369 ±0.140	1.474 ±0.220	0.311 ±0.082	0.535 ±0.111	1.139 ±0.065
IVT DSP4	0.693 ±0.075	0.387 ±0.082	1.205 ±0.089	0875 ±0.130	0.086 ±0.011	0.155 ±0.026	1.173 ±0.193	1.229 ±0.101	0.249 ±0.036	0.491 ±0.074	0.987 ±0.114

Contents of major monoamines and metabolites in frontal cortex and hypothalamus of mice previously injected ivt with saline or 75 ug dsp4. Concentrations are ng per mg of tissue.